Patient Preferences Associated with Anti-Vascular Endothelial Growth Factor Therapies for Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema

Davis Bhagat1 University Retina and Macula Associates, Oak Forest, IL, USA

https://orcid.org/0000-0002-5265-8475

Breanne Kirby1 University Retina and Macula Associates, Oak Forest, IL, USA

Harit Bhatt1 University Retina and Macula Associates, Oak Forest, IL, USA;2 University of Illinois, Chicago, IL, USA

Rama Jager1 University Retina and Macula Associates, Oak Forest, IL, USA;2 University of Illinois, Chicago, IL, USA

Meena George1 University Retina and Macula Associates, Oak Forest, IL, USA;2 University of Illinois, Chicago, IL, USA

https://orcid.org/0000-0001-6115-7229

Veeral Sheth1 University Retina and Macula Associates, Oak Forest, IL, USA;2 University of Illinois, Chicago, IL, USACorrespondence[email protected]

Citations (7)

Keep up to date with the latest research on this topic with citation updates for this article.

Articles from other publishers (7)

Manuel Vargas-Peirano, Catalina Verdejo, Laura Vergara-Merino, Cristóbal Loézar, Martin Hoehmann & Javier Pérez-Bracchiglione. (2023) Intravitreal antivascular endothelial growth factor in diabetic macular oedema: scoping review of clinical practice guidelines recommendations. British Journal of Ophthalmology 107:3, pages 313-319.
Crossref

Richard P. Gale, Robert P. Finger, Bora Eldem, Tariq Aslam, Jane Barratt, Vincent Daien, Laurent Kodjikian, Anat Loewenstein, Mali Okada, Tien Yin Wong, Michelle Sylvanowicz & Francisco J. Rodríguez. (2022) The management of neovascular age‐related macular degeneration: A systematic literature review of patient‐reported outcomes, patient mental health and caregiver burden. Acta Ophthalmologica 101:1.
Crossref

Semra Ozdemir, Eric Finkelstein, Jia Jia Lee, Issac Horng Khit Too, Kelvin Yi Chong Teo, Anna Chen Sim Tan, Tien Yin Wong & Gemmy Chui Ming Cheung. (2022) Understanding patient preferences in anti-VEGF treatment options for age-related macular degeneration. PLOS ONE 17:8, pages e0272301.
Crossref

Margaret A. Chang, Audrey Kapre, Derrick Kaufman, David R. Kardatzke, Melvin Rabena, Shienal Patel, Ashwini Bobbala, Shamika Gune, Anne Fung & Gene Wallenstein. (2022) Patient Preference and Treatment Satisfaction With a Port Delivery System for Ranibizumab vs Intravitreal Injections in Patients With Neovascular Age-Related Macular Degeneration. JAMA Ophthalmology 140:8, pages 771.
Crossref

Basem Al-Omari, Joviana Farhat & Mai Ershaid. (2022) Conjoint Analysis: A Research Method to Study Patients’ Preferences and Personalize Care. Journal of Personalized Medicine 12:2, pages 274.
Crossref

Roberto Gallego-Pinazo, Begoña Pina-Marin, Marta Comellas, Susana Aceituno, Laia Gómez-Baldó & Carles Blanch. (2021) Patient and retina specialists’ preferences in neovascular age-related macular degeneration treatment. A discrete choice experiment. PLOS ONE 16:12, pages e0261955.
Crossref

R.R. Fayzrakhmanov, V.Yu. Voropaev, A.V. Sukhanova & E.O. Shatalova. (2021) Antiangiogenic therapy of neovascular age-related macular degeneration. Vestnik oftal'mologii 137:1, pages 83.
Crossref

Patient Preferences Associated with Anti-Vascular Endothelial Growth Factor Therapies for Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema

Articles from other publishers (7)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Patient Preferences Associated with Anti-Vascular Endothelial Growth Factor Therapies for Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema

Citations (7)

Articles from other publishers (7)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date